Download - Fitbit patent suit against Jawbone
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
FITBIT, INC., Plaintiff, v. ALIPHCOM d/b/a JAWBONE and BODYMEDIA, INC., Defendants.
))))))))))
C.A. No. DEMAND FOR JURY TRIAL
COMPLAINT FOR PATENT INFRINGEMENT
Plaintiff Fitbit, Inc. (“Fitbit”), by and through its attorneys, for its complaint against
AliphCom d/b/a Jawbone and BodyMedia, Inc. (“Defendants”), hereby alleges as follows:
THE PARTIES
1. Fitbit is a Delaware corporation with its principal place of business located at 405
Howard Street, San Francisco, CA 94015.
2. On information and belief, AliphCom is a California corporation with its principal
place of business located in San Francisco, California.
3. On information and belief, BodyMedia, Inc., is a Delaware corporation with its
principal place of business located in Pittsburgh, Pennsylvania.
4. On information and belief, BodyMedia is a wholly owned subsidiary of
AliphCom.
JURISDICTION AND VENUE
5. This action for patent infringement arises under federal law, and this Court has
jurisdiction pursuant to 28 U.S.C. §§ 1331, 1338 and the Patent Laws of the United States, 35
U.S.C. § 1, et seq.
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 1 of 11 PageID #: 1Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 2 of 125
2
6. This Court has personal jurisdiction over Defendant AliphCom because, inter
alia, AliphCom maintains continuous and systematic contacts with this judicial district. Either
directly, or through its subsidiaries, agents, and/or affiliates, AliphCom has conducted and
continues to conduct business in this judicial district, including by manufacturing, marketing,
and selling infringing products throughout the United States and in the District of Delaware.
These acts cause injury to Fitbit within this judicial district.
7. This Court has personal jurisdiction over Defendant BodyMedia, Inc. because,
inter alia, BodyMedia is a Delaware corporation and maintains continuous and systematic
contacts with this judicial district. Either directly, or through its subsidiaries, agents, and/or
affiliates, BodyMedia has conducted and continues to conduct business in this judicial district,
including by manufacturing, marketing, and selling infringing products throughout the United
States and in the District of Delaware. These acts cause injury to Fitbit within this judicial
district.
8. Venue is proper in this court pursuant to 28 U.S.C. §§ 1391(b), (c), and 1400(b).
Defendant BodyMedia is a Delaware corporation. Defendants have committed acts of
infringement within this district, and a substantial part of the events giving rise to the claim
occurred in this District.
PATENTS-IN-SUIT
9. U.S. Patent No. 9,031,812 (the “’812 patent”), entitled “Notifications On A User
Device Based On Activity Detected By An Activity Monitoring Device,” was duly and legally
issued by the U.S. Patent and Trademark Office on May 12, 2015. The ’812 patent is assigned to
Fitbit. A true and correct copy of the ’812 patent is attached as Exhibit A.
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 2 of 11 PageID #: 2Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 3 of 125
3
10. U.S. Patent No. 8,909,543 (the “’543 patent”), entitled “Methods for Detecting
and Recording Physical Activity of Person,” was duly and legally issued by the U.S. Patent and
Trademark Office on December 9, 2014. The ’543 patent is assigned to Fitbit. A true and
correct copy of the ’543 patent is attached as Exhibit B.
11. U.S. Patent No. 9,042,971 (the “’971 patent”), entitled “Biometric Monitoring
Device With Heart Rate Measurement Activated By A Single User Gesture,” was duly and
legally issued by the U.S. Patent and Trademark Office on May 26, 2015. The ’971 patent is
assigned to Fitbit. A true and correct copy of the ’971 patent is attached as Exhibit C.
12. The ’812 patent, ’543 patent, and ’971 patent are collectively referred to herein as
the “Patents-in-Suit.” By assignment, Fitbit owns all right, title, and interest in and to the
Patents-in-Suit. Fitbit has the right to sue and recover for the infringement of the Patents-in-Suit.
BACKGROUND
13. Fitbit, Inc. is a company that helps people lead healthier, more active lives by
empowering them with data, inspiration, and guidance to reach their goals. Fitbit is an innovator
in the health and fitness market, addressing key needs with advanced technology embedded in
cutting-edge but simple-to-use products and services. Since 2007, Fitbit has pioneered the
connected health and fitness market, growing rapidly into a leading global health and fitness
brand.
14. Fitbit wearable devices track sleep and activity. The Fitbit product line includes
the Fitbit Zip, Fitbit One, Fitbit Flex, Fitbit Charge, Fitbit Charge HR, and Fitbit Surge.
15. Defendants manufacture, market, and sell activity trackers—including the UP
Move, UP24, UP2, UP3, and UP4—that infringe one or more of the Patents-in-Suit.
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 3 of 11 PageID #: 3Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 4 of 125
4
Defendants’ activity trackers are used in conjunction with the UP App, made available by
Defendants as part of the “UP System.”
16. On information and belief, AliphCom acquired BodyMedia, Inc. in April 2013
and incorporated BodyMedia’s “multi-sensor approach” to physiological data collection and
other BodyMedia technology into subsequent products. Products incorporating multiple sensors,
such as temperature sensors and bioimpedance sensors, include at least the UP3 and UP4. On
information and belief, BodyMedia has contributed to the design, development, manufacture,
marketing, and/or sale of at least the UP Move, UP3 and UP4 devices.
COUNT I (Infringement of U.S. Patent No. 9,031,812)
17. Fitbit realleges paragraphs 1 through 16 as though fully set forth herein.
18. In violation of 35 U.S.C. § 271, Defendants have infringed and continue to
infringe the ’812 patent in this judicial district and elsewhere in the United States, both literally
and under the doctrine of equivalents. Defendants have infringed and have continued to infringe
through the manufacture, use, offer for sale, sale, and/or importation of products, associated
software, and components, including, without limitation, the UP Move, UP24, UP2, UP3, and
UP4 and the UP App software interface.
19. On information and belief, at least from the service of this Complaint, Defendants
will contributorily infringe and/or actively induce infringement of the ’812 patent in violation of
35 U.S.C. § 271(b)-(c), with knowledge of or willful blindness to the existence of the ’812
patent, with specific intent to contributorily infringe and/or to induce infringement, and with
knowledge or willful blindness that the induced acts would constitute patent infringement. On
information and belief, each of the UP Move, UP24, UP2, UP3, and UP4, each sold or offered
for sale by Defendants, is not a staple article of commerce, is a component of a patented
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 4 of 11 PageID #: 4Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 5 of 125
5
combination and material to practicing the invention in the claims of the ’812 patent, and has no
substantial non-infringing uses. These products are sold directly to customers and used by
customers to track and record physical activity in conjunction with the UP App in a manner that
infringes the ’812 patent.
20. AliphCom’s indirect infringement will occur by AliphCom’s engaging in at least
the following activities: designing and manufacturing the UP Move, UP24, UP2, UP3, and UP4
devices and their components specifically for sale and use in the United States, including
Delaware; selling and offering to sell these devices and their components in the United States or
importing these devices and their components into the United States, including Delaware; and
soliciting, encouraging, and enabling infringing activity in the United States, including
Delaware, through promotional and instructional materials, websites (including support
information, video instructions, tutorials, and frequently asked questions that direct customers to
use the devices in an infringing manner), activities relating to activity monitors or the UP Move,
UP24, UP2, UP3, and UP4 devices, and by providing access to and encouraging use of the UP
App and promoting the use of third-party applications.
21. BodyMedia’s indirect infringement will occur by BodyMedia engaging in at least
the following activities: designing and manufacturing at least the UP Move, UP3, and UP4
devices and their components specifically for sale and use in the United States, including
Delaware; and selling and offering to sell these devices and their components in the United
States or importing these devices and their components into the United States, including
Delaware.
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 5 of 11 PageID #: 5Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 6 of 125
6
22. Defendants’ acts of infringement of the ’812 patent have caused and will continue
to cause Fitbit substantial and irreparable injury, for which Fitbit is entitled to receive injunctive
relief and damages adequate to compensate Fitbit for such infringement.
23. This case is exceptional, and therefore, Fitbit is entitled to attorneys’ fees pursuant
to 35 U.S.C. § 285.
24. Fitbit is also entitled to damages under 35 U.S.C. § 284 for Defendants’
infringement of one or more claims of the ’812 patent.
COUNT II (Infringement of U.S. Patent No. 8,909,543)
25. Fitbit realleges paragraphs 1 through 24 as though fully set forth herein.
26. In violation of 35 U.S.C. § 271, Defendants have infringed and continue to
infringe the ’543 patent in this judicial district and elsewhere in the United States, both literally
and under the doctrine of equivalents. Defendants have infringed and have continued to infringe
through the manufacture, use, offer for sale, sale, and/or importation of products, associated
software, and components, including, without limitation, the UP Move activity tracker and the
UP App software interface.
27. On information and belief, at least from the service of this Complaint, Defendants
will contributorily infringe and/or actively induce infringement of the ’543 patent in violation of
35 U.S.C. § 271(b)-(c), with knowledge of or willful blindness to the existence of the ’543
patent, with specific intent to contributorily infringe and/or to induce infringement, and with
knowledge or willful blindness that the induced acts would constitute patent infringement. On
information and belief, the UP Move and other activity trackers, each sold or offered for sale by
Defendants, is not a staple article of commerce, is a component of a patented combination and
material to practicing the invention in the claims of the ’543 patent, and has no substantial non-
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 6 of 11 PageID #: 6Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 7 of 125
7
infringing uses. These products are sold directly to customers and used by customers to track
and record physical activity in conjunction with the UP App in a manner that infringes the ’543
patent.
28. AliphCom’s indirect infringement will occur by AliphCom’s engaging in at least
the following activities: designing and manufacturing the UP Move and other activity tracker
devices and their components specifically for sale and use in the United States, including
Delaware; selling and offering to sell these devices and their components in the United States or
importing these devices and their components into the United States, including Delaware; and
soliciting, encouraging, and enabling infringing activity in the United States, including
Delaware, through promotional and instructional materials, websites (including support
information, video instructions, tutorials, and frequently asked questions that direct customers to
use the devices in an infringing manner), activities relating to activity monitors or the UP Move
devices, and by providing access to and encouraging use of the UP App and promoting the use of
third-party applications.
29. BodyMedia’s indirect infringement will occur by BodyMedia engaging in at least
the following activities: designing and manufacturing at least the UP Move and other activity
tracker devices and their components specifically for sale and use in the United States, including
Delaware; and selling and offering to sell these devices and their components in the United
States or importing these devices and their components into the United States, including
Delaware.
30. Defendants’ acts of infringement of the ’543 patent have caused and will continue
to cause Fitbit substantial and irreparable injury, for which Fitbit is entitled to receive injunctive
relief and damages adequate to compensate Fitbit for such infringement.
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 7 of 11 PageID #: 7Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 8 of 125
8
31. This case is exceptional, and therefore, Fitbit is entitled to attorneys’ fees pursuant
to 35 U.S.C. § 285.
32. Fitbit is also entitled to damages under 35 U.S.C. § 284 for Defendants’
infringement of one or more claims of the ’543 patent.
COUNT III (Infringement of U.S. Patent No. 9,042,971)
33. Fitbit realleges paragraphs 1 through 32 as though fully set forth herein.
34. In violation of 35 U.S.C. § 271, Defendants have infringed and continue to
infringe the ’971 patent in this judicial district and elsewhere in the United States, both literally
and under the doctrine of equivalents. Defendants have infringed and have continued to infringe
through the manufacture, use, offer for sale, sale, and/or importation of products, associated
software, and components, including, without limitation, the UP3 and UP4 activity trackers and
the UP App software interface.
35. On information and belief, at least from the service of this Complaint, Defendants
will contributorily infringe and/or actively induce infringement of the ’971 patent in violation of
35 U.S.C. § 271(b)-(c), with knowledge of or willful blindness to the existence of the ’971
patent, with specific intent to contributorily infringe and/or to induce infringement, and with
knowledge or willful blindness that the induced acts would constitute patent infringement. On
information and belief, each of the UP3 and UP4, each sold or offered for sale by Defendants, is
not a staple article of commerce, is a component of a patented combination and material to
practicing the invention in the claims of the ’971 patent, and has no substantial non-infringing
uses. These products are sold directly to customers and used by customers to track and record
physical activity in conjunction with the UP App in a manner that infringes the ’971 patent.
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 8 of 11 PageID #: 8Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 9 of 125
9
36. AliphCom’s indirect infringement will occur by AliphCom’s engaging in at least
the following activities: designing and manufacturing the UP3 and UP4 and other activity tracker
devices and their components specifically for sale and use in the United States, including
Delaware; selling and offering to sell these devices and their components in the United States or
importing these devices and their components into the United States, including Delaware; and
soliciting, encouraging, and enabling infringing activity in the United States, including
Delaware, through promotional and instructional materials, websites (including support
information, video instructions, tutorials, and frequently asked questions that direct customers to
use the devices in an infringing manner), activities relating to activity monitors or the UP3 and
UP4 devices, and by providing access to and encouraging use of the UP App and promoting the
use of third-party applications.
37. BodyMedia’s indirect infringement will occur by BodyMedia engaging in at least
the following activities: designing and manufacturing the UP3 and UP4 and other activity tracker
devices and their components specifically for sale and use in the United States, including
Delaware; and selling and offering to sell these devices and their components in the United
States or importing these devices and their components into the United States, including
Delaware.
38. Defendants’ acts of infringement of the ’971 patent have caused and will continue
to cause Fitbit substantial and irreparable injury, for which Fitbit is entitled to receive injunctive
relief and damages adequate to compensate Fitbit for such infringement.
39. This case is exceptional, and therefore, Fitbit is entitled to attorneys’ fees pursuant
to 35 U.S.C. § 285.
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 9 of 11 PageID #: 9Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 10 of 125
10
40. Fitbit is also entitled to damages under 35 U.S.C. § 284 for Defendants’
infringement of one or more claims of the ’971 patent.
JURY DEMAND
41. Pursuant to Rule 38(b) of the Federal Rules of Civil Procedure, Fitbit respectfully
requests a trial by jury on all issues.
REQUESTED RELIEF
Fitbit respectfully seeks the following relief:
a) The entry of judgment declaring that Defendants have infringed each of the
Patents-in-Suit;
b) An award of all available damages, including, but not limited to Fitbit’s lost
profits from Defendants’ infringement of the Patents-in-Suit, but in any event not less than a
reasonable royalty, together with pre-judgment and post-judgment interest;
c) An injunction restraining Defendants and their affiliates, subsidiaries, officers,
directors, agents, servants, employees, representatives, licensees, successors, assigns, and all
those acting for them and on their behalf, from further infringement, further inducements of
infringement, and further contributions to infringement of the Patents-in-Suit;
d) The entry of an order declaring that this is an exceptional case and awarding Fitbit
its costs, expenses, and reasonable attorney fees under 35 U.S.C. § 285 and all other applicable
statutes, rules, and common law; AND
e) An order awarding Fitbit any such other relief as the Court may deem just and
proper under the circumstances.
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 10 of 11 PageID #: 10Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 11 of 125
11
OF COUNSEL: Josh A. Krevitt GIBSON, DUNN & CRUTCHER LLP 200 Park Avenue New York, New York 10166 (212) 351-4000 Wayne M. Barsky GIBSON, DUNN & CRUTCHER LLP 2029 Century Park East Los Angeles, CA 90067-3026 (310) 552-8500 Frederick S. Chung Stuart M. Rosenberg Alison Watkins GIBSON, DUNN & CRUTCHER LLP 1881 Page Mill Road Palo Alto, CA 94304 (650) 849-5392
MORRIS, NICHOLS, ARSHT & TUNNELL LLP /s/ Jack B. Blumenfeld Jack B. Blumenfeld (#1014) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899 (302) 658-9200 Attorneys for Plaintiff
September 3, 2015
Case 1:15-cv-00775-UNA Document 1 Filed 09/03/15 Page 11 of 11 PageID #: 11Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 12 of 125
EXHIBIT A
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 1 of 111 PageID #: 12Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 13 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 2 of 111 PageID #: 13Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 14 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 3 of 111 PageID #: 14Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 15 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 4 of 111 PageID #: 15Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 16 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 5 of 111 PageID #: 16Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 17 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 6 of 111 PageID #: 17Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 18 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 7 of 111 PageID #: 18Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 19 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 8 of 111 PageID #: 19Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 20 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 9 of 111 PageID #: 20Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 21 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 10 of 111 PageID #: 21Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 22 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 11 of 111 PageID #: 22Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 23 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 12 of 111 PageID #: 23Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 24 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 13 of 111 PageID #: 24Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 25 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 14 of 111 PageID #: 25Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 26 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 15 of 111 PageID #: 26Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 27 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 16 of 111 PageID #: 27Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 28 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 17 of 111 PageID #: 28Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 29 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 18 of 111 PageID #: 29Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 30 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 19 of 111 PageID #: 30Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 31 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 20 of 111 PageID #: 31Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 32 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 21 of 111 PageID #: 32Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 33 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 22 of 111 PageID #: 33Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 34 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 23 of 111 PageID #: 34Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 35 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 24 of 111 PageID #: 35Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 36 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 25 of 111 PageID #: 36Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 37 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 26 of 111 PageID #: 37Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 38 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 27 of 111 PageID #: 38Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 39 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 28 of 111 PageID #: 39Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 40 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 29 of 111 PageID #: 40Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 41 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 30 of 111 PageID #: 41Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 42 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 31 of 111 PageID #: 42Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 43 of 125
EXHIBIT B
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 32 of 111 PageID #: 43Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 44 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 33 of 111 PageID #: 44Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 45 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 34 of 111 PageID #: 45Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 46 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 35 of 111 PageID #: 46Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 47 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 36 of 111 PageID #: 47Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 48 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 37 of 111 PageID #: 48Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 49 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 38 of 111 PageID #: 49Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 50 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 39 of 111 PageID #: 50Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 51 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 40 of 111 PageID #: 51Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 52 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 41 of 111 PageID #: 52Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 53 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 42 of 111 PageID #: 53Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 54 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 43 of 111 PageID #: 54Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 55 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 44 of 111 PageID #: 55Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 56 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 45 of 111 PageID #: 56Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 57 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 46 of 111 PageID #: 57Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 58 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 47 of 111 PageID #: 58Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 59 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 48 of 111 PageID #: 59Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 60 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 49 of 111 PageID #: 60Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 61 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 50 of 111 PageID #: 61Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 62 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 51 of 111 PageID #: 62Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 63 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 52 of 111 PageID #: 63Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 64 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 53 of 111 PageID #: 64Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 65 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 54 of 111 PageID #: 65Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 66 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 55 of 111 PageID #: 66Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 67 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 56 of 111 PageID #: 67Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 68 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 57 of 111 PageID #: 68Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 69 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 58 of 111 PageID #: 69Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 70 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 59 of 111 PageID #: 70Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 71 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 60 of 111 PageID #: 71Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 72 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 61 of 111 PageID #: 72Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 73 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 62 of 111 PageID #: 73Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 74 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 63 of 111 PageID #: 74Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 75 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 64 of 111 PageID #: 75Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 76 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 65 of 111 PageID #: 76Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 77 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 66 of 111 PageID #: 77Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 78 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 67 of 111 PageID #: 78Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 79 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 68 of 111 PageID #: 79Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 80 of 125
EXHIBIT C
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 69 of 111 PageID #: 80Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 81 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 70 of 111 PageID #: 81Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 82 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 71 of 111 PageID #: 82Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 83 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 72 of 111 PageID #: 83Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 84 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 73 of 111 PageID #: 84Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 85 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 74 of 111 PageID #: 85Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 86 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 75 of 111 PageID #: 86Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 87 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 76 of 111 PageID #: 87Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 88 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 77 of 111 PageID #: 88Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 89 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 78 of 111 PageID #: 89Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 90 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 79 of 111 PageID #: 90Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 91 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 80 of 111 PageID #: 91Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 92 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 81 of 111 PageID #: 92Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 93 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 82 of 111 PageID #: 93Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 94 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 83 of 111 PageID #: 94Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 95 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 84 of 111 PageID #: 95Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 96 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 85 of 111 PageID #: 96Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 97 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 86 of 111 PageID #: 97Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 98 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 87 of 111 PageID #: 98Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 99 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 88 of 111 PageID #: 99Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 100 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 89 of 111 PageID #: 100Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 101 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 90 of 111 PageID #: 101Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 102 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 91 of 111 PageID #: 102Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 103 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 92 of 111 PageID #: 103Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 104 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 93 of 111 PageID #: 104Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 105 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 94 of 111 PageID #: 105Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 106 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 95 of 111 PageID #: 106Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 107 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 96 of 111 PageID #: 107Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 108 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 97 of 111 PageID #: 108Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 109 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 98 of 111 PageID #: 109Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 110 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 99 of 111 PageID #: 110Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 111 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 100 of 111 PageID #: 111Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 112 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 101 of 111 PageID #: 112Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 113 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 102 of 111 PageID #: 113Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 114 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 103 of 111 PageID #: 114Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 115 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 104 of 111 PageID #: 115Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 116 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 105 of 111 PageID #: 116Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 117 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 106 of 111 PageID #: 117Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 118 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 107 of 111 PageID #: 118Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 119 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 108 of 111 PageID #: 119Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 120 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 109 of 111 PageID #: 120Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 121 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 110 of 111 PageID #: 121Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 122 of 125
Case 1:15-cv-00775-UNA Document 1-1 Filed 09/03/15 Page 111 of 111 PageID #: 122Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 123 of 125
CIVIL COVER SHEET
(SEE INSTRUCTIONS ON NEXT PAGE OF THIS FORM.)
I. (a) PLAINTIFFS DEFENDANTS
(b)(EXCEPT IN U.S. PLAINTIFF CASES) (IN U.S. PLAINTIFF CASES ONLY)
(c) (Firm Name, Address, and Telephone Number) (If Known)
II. BASIS OF JURISDICTION (Place an “X” in One Box Only) III. CITIZENSHIP OF PRINCIPAL PARTIES (Place an “X” in One Box for Plaintiff(For Diversity Cases Only) and One Box for Defendant)
PTF DEF PTF DEF(U.S. Government Not a Party) or
and(Indicate Citizenship of Parties in Item III)
IV. NATURE OF SUIT (Place an “X” in One Box Only)CONTRACT TORTS FORFEITURE/PENALTY BANKRUPTCY OTHER STATUTES
PERSONAL INJURY PERSONAL INJURY
PROPERTY RIGHTS
LABOR SOCIAL SECURITY PERSONAL PROPERTY
REAL PROPERTY CIVIL RIGHTS PRISONER PETITIONS FEDERAL TAX SUITSHabeas Corpus:
IMMIGRATIONOther:
V. ORIGIN (Place an “X” in One Box Only)
(specify)
VI. CAUSE OF ACTION
(Do not cite jurisdictional statutes unless diversity)
VII. REQUESTED IN COMPLAINT:
CLASS ACTION DEMAND $
JURY DEMAND:
VIII. RELATED CASE(S) IF ANY (See instructions):
FOR OFFICE USE ONLY
FITBIT, INC.
Jack B. Blumenfeld 302-658-9200Morris, Nichols, Arsht & Tunnell LLP1201 North Market Street; P.O. Box 1347; Wilmington, DE 19899
ALIPHCOM d/b/a JAWBONE and BODYMEDIA, INC.
35 U.S.C. § 271
Patent Infringement
09/03/2015 /s/ Jack B. Blumenfeld
Case 1:15-cv-00775-UNA Document 1-2 Filed 09/03/15 Page 1 of 2 PageID #: 123Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 124 of 125
INSTRUCTIONS FOR ATTORNEYS COMPLETING CIVIL COVER SHEET FORM JS 44
I.(a) Plaintiffs-Defendants.
(b) County of Residence.
(c) Attorneys.
II. Jurisdiction.
. ; NOTE: federal question actions take precedence over diversity cases.
III. Residence (citizenship) of Principal Parties.
IV. Nature of Suit.
V. Origin.
VI. Cause of Action. Do not cite jurisdictional statutes unless diversity.
VII. Requested in Complaint.
VIII. Related Cases.
Date and Attorney Signature.
Case 1:15-cv-00775-UNA Document 1-2 Filed 09/03/15 Page 2 of 2 PageID #: 124Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 125 of 125